Iovance Biotherapeutics Inc logo

Iovance Biotherapeutics Inc

1
NAS:IOVA (USA)  
$ 8.69 +0.35 (+4.2%) 10:08 PM EST
At Loss
P/B:
3.57
Volume:
3.95M
Avg Vol (2M):
7.28M
Trade In:
Volume:
3.95M
At Loss
Avg Vol (2M):
7.28M

Business Description

Description
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Name Current Vs Industry Vs History
Cash-To-Debt 4.22
Equity-to-Asset 0.78
Debt-to-Equity 0.12
Debt-to-EBITDA -0.2
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.64
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.52
9-Day RSI 56.24
14-Day RSI 52.96
6-1 Month Momentum % 2.96
12-1 Month Momentum % 4.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.63
Quick Ratio 4.42
Cash Ratio 4.28
Days Inventory 237.57
Days Sales Outstanding 26.71
Days Payable 570.62

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.4
Shareholder Yield % -17.12

Financials (Next Earnings Date:2024-08-08 Est.)

IOVA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IOVA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Iovance Biotherapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.904
EPS (TTM) ($) -1.8
Beta 1.01
Volatility % 138.82
14-Day RSI 52.96
14-Day ATR ($) 0.543182
20-Day SMA ($) 8.158
12-1 Month Momentum % 4.43
52-Week Range ($) 3.21 - 18.33
Shares Outstanding (Mil) 279.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Iovance Biotherapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Iovance Biotherapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Iovance Biotherapeutics Inc Frequently Asked Questions

What is Iovance Biotherapeutics Inc(IOVA)'s stock price today?
The current price of IOVA is $8.69. The 52 week high of IOVA is $18.33 and 52 week low is $3.21.
When is next earnings date of Iovance Biotherapeutics Inc(IOVA)?
The next earnings date of Iovance Biotherapeutics Inc(IOVA) is 2024-08-08 Est..
Does Iovance Biotherapeutics Inc(IOVA) pay dividends? If so, how much?
Iovance Biotherapeutics Inc(IOVA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1